BioTrinity 2010 Sponsors and Project Partners

 Platinum Sponsors

OSI Pharmaceuticals

OSI Pharmaceuticals is committed to “shaping medicine and changing lives” by discovering, developing and commercializing high-quality, novel and differentiated personalized medicines designed to extend life and improve the quality of life for patients with cancer and diabetes/obesity.

We specialize in the discovery and development of innovative molecular targeted therapies that address significant unmet medical needs, and strive to turn pioneering science into breakthrough therapies for patients suffering from life-threatening diseases.

Our Oncology business is anchored by our flagship product, Tarceva® (erlotinib), a small molecule inhibitor of the epidermal growth factor receptor, or EGFR, that was first discovered and developed by OSI. Tarceva is the only EGFR inhibitor to have demonstrated the ability to improve overall survival in advanced non-small cell lung cancer and advanced pancreatic cancer. Behind Tarceva, we have an emerging oncology pipeline of molecular targeted therapies in clinical and late-stage pre-clinical development. Our R & D strengths include high-throughput screening, chemical libraries, medicinal and combinational chemistry and automated drug profiling technology platforms. We are leveraging our understanding of Epithelial-Mesenchymal Transition (EMT) to develop molecular targeted therapies (MTTS) and to become a leader in the science underpinning EMT in cancer.

Our diabetes and obesity R & D programs are conducted through Prosidion Limited, our U.K. subsidiary dedicated to the discovery and development of novel therapies for metabolic diseases, particularly type 2 diabetes and obesity. Our diabetes/obesity group has an emerging diabetes and obesity clinical pipeline with several innovative drug candidates that have progressed into clinical development. We believe our emerging neuroendocrine control with body weight and glycemia platform can be used to pioneer personalized medicine approaches in diabetes and obesity.

OSI has a dedicated team of approximately 500 research and development, regulatory, sales, marketing, commercial, and business professionals. We are headquartered in Long Island, New York with facilities in Colorado, New Jersey and the United Kingdom.

 

 Gold Sponsors

Technomark Life Sciences

 

Technomark's global reach creates value within the life-science industry by using a partnering and hands-on approach to implement innovative strategies for product development and corporate growth.

 Silver Sponsors

Ontario’s Ministry of Economic Development and Trade, Canada

The mandate of Ontario’s Ministry of Economic Development and Trade is to promote economic growth. The International Trade Branch supports the ministry’s mandate by connecting business in Ontario and throughout the world with the people, products and ideas that make Ontario “Canada’s Economic Powerhouse”. To this end, Ontario International Trade Branch has organised a biotech delegation with representatives of 6 Ontario companies to attend BioTrinity: AllPhase Clinical Research; Axela Inc; Cytochroma Inc.; Miami Mice; PlantForm, Corporation and Thornhill Research Inc.

 AllPhase Clinical Research - Canadian Trade Mission

provides integrated clinical trial services that allow international partners to conduct trials in Canada while reinforcing their global development capabilities through Health Canada and FDA approvals.

Axela Inc - Canadian Trade Mission

provides a novel portfolio of next generation multiplex tools and diagnostic tests that provide enhanced analysis of proteins, pathogens, DNA and RNA and are targeted at biomarker testing in clinical research and diagnostics.

Miami Mice - Canadian Trade Mission

Research Corp licenses its mouse models of lung cancer, leukemia and angiogenesis and is developing a diagnostic kit for early lung cancer detection.

PlantForm Corporation - Canadian Trade Mission

is licensing the rights to proprietary technology for the manufacture of biological drug substances in plants and is currently developing Herceptin from tobacco plants.

Thornhill Research Inc- Canadian Trade Mission

develops, manufactures, licenses and sells products based on technologies that control gas concentrations in the lung and in the blood stream including MOVESTM (mini-ICU); ClearMateTM (carbon monoxide); DuoCheckTM (drug safety); RespirActTM (CVR); and ACCU-FlickTM (cardiac monitor).

Teva Pharmaceutical Industries Ltd

Teva Pharmaceutical Industries Ltd is a global pharmaceutical company specializing in the development, production and marketing of generic and proprietary branded pharmaceuticals as well as active pharmaceutical ingredients. Teva is among the top 20 pharmaceutical companies and among the largest generic pharmaceutical companies in the world.

Fry Heath & Spence LLP

Fry Heath & Spence LLP is a long-established firm of UK and European patent and trade mark attorneys, providing business-focused expertise to protect your legal rights in intellectual property (IP) matters worldwide.
We offer a full range of legal services relating to patents, trade marks, designs and copyright. What distinguishes us from our competitors is the emphasis we put on personal contact with our clients and our ability to take a pragmatic, commercial view as well as a legal one. The wealth of expertise and experience we have built up and the far-ranging technical skills of our attorneys enable us to offer a comprehensive range of intellectual property services.

Merck Sharp & Dohme

Merck & Co., Inc., USA, is a global research-driven pharmaceutical company dedicated to putting patients first. Merck discovers, develops, manufactures, and markets vaccines and medicines in over 20 therapeutic categories directly and through its joint ventures. Our mission is to provide society with superior products and services by developing innovations and solutions that improve the quality of life.

At Merck, our strategy for growth is based on breakthrough research - both internal and external through partnerships - and demonstrating the value of our medicines to patients, payers, and providers. Worldwide sales in 2005 were $22 billion and Merck continues to invest heavily in research and development.

SEEDA

SEEDA has one aim - to support the economic development of this world-class region. We work at a local, regional, national and international level to attract inward investment, to help businesses reach their full potential and to win practical support from a range of partners. We bring funding into the region to help the economic growth of the South East.

SEEDA's vision is to be the best economic development agency a top global region could have:

  • With expert interventions;
  • Expert deal making; and
  • Expert strategic advice.

We provide businesses with the support they need to grow, through our in-depth knowledge of their needs and the economic conditions, in which they operate.

Shire

Shire's strategic goal is to become the leading specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician. Shire focuses its business on attention deficit and hyperactivity disorder, human genetic therapies and gastrointestinal diseases. Shire believes that a carefully selected portfolio of products with a strategically aligned and relatively small-scale sales force will deliver strong results. 

 Bronze Sponsors

FOCUS

Protecting Assets - Increasing Wealth

FOCUS Insurance provides specialist guidance and advice on the full range of business Insurance to the Life/Bioscience and Diagnostics marketplace.  Utilising the country’s leading insurers FOCUS undertake risk assessments with clients and create a tailor made business and asset protection solution.  New and emerging businesses can benefit from specifically designed packages for spin out and newly established enterprises.  FOCUS Employee Benefits specialise in the design and implementation of market leading Employee benefits to the same markets, this can include Pensions, death in service, health insurance and keyperson protection.

James Cowper Accountants and Advisors

As a leading firm of accountants and business advisors, James Cowper's aim is simple - to draw on our experience and expertise to help you achieve eral success. Fresh thinking, diverse skills and a sharp eye for the broader pictures mean that together, we can really make things happen.

What sets James Cowper apart from the rest of the UK's top accountants and business advisers? Professionalism, flexibility, but above all, passion. Our clients? As varied as our skills, each advised according to their specific needs. Each equally important to us.We have decades of experience behind us but our knowledge is 'in the now' and our vision trained on the future. Whatever your requirement - be it starting out with a new business venture, flotation or tax planning for the private client - we have the breadth of expertise to help you achieve real success. OBN chose James Cowper as its accountancy firm because of its expertise with technology-based businesses.

KBC Peel Hunt

We are a UK equity specialist that takes a unique approach to follow Healthcare, Medical Technology and Biotechnology in tandem. We believe that each has a huge part to play in the others' future success and development. With a specialist team dedicated to these areas, we are in a strong position to advise both corporate and institutional investors on important trends, developments and ultimately investments.

Manches LLP

Manches LLP is a leading law firm with offices in Oxford and London. The Firm offers the full range of company and commercial legal services with a particular emphasis on the life science sector. Of the eight specialist pharmaceutical and biotechnology lawyers listed by Legal 500 for the South East England, three are partners at Manches. The firm has the largest specialist group of lawyers in the South East (excluding London). Typical services to clients involve:

  • Establishment, seed funding and funding rounds
  • Listing or trade sale
  • Collaborative research agreements
  • Use of project results and background technology
  • Setting up spin-outs and joint ventures
  • Securing IPR
  • In-licensing and out-licensing
  • Co-development and co-marketing
  • Clinical manufacturing, clinical supply and clinical trials
  • Distribution and supply
  • Domestic and foreign litigation

MP Biomedicals

MP Biomedicals is a worldwide corporation committed to the development, manufacturing and marketing of life science and diagnostics products. The company is dedicated to providing scientists and researchers with the most innovative and highest quality tool, combined with superior service to aid them in their quest for ground-breaking discovery and turning the hope for life-changing solutions into a reality.

MP Biomedicals offers a line of more than 55.000 life science research and diagnostic products (in the field of Molecular Biology, Cell Biology, Immunology, Biochemicals, Rapid Diagnostic, EIA/RIA Diagnostic, etc…) that support academic and government research institutions as well as pharmaceutical and biotechnology companies.

No matter how dynamic the evolution of the life science and biotechnology field, MP Biomedicals’ team remains committed to supporting customers in their effort to make new discoveries. From basic research, through scale-up, to full-scale production and diagnostic testing, MP Biomedicals serves every industry need.

PharmaNet

PharmaNet Development Group, a global drug development services company, provides clinical development solutions including consulting services, Phase I clinical studies, bioequivalency and pharmacodynamic studies, bioanalytical analyses and Phase II, III, and IV clinical development studies.

 

PharmaNet offers a comprehensive range of services for early stage programs including Phase I/IIa and bioequivalence studies and bioanalytical services. Our global network of resources includes three clinics and two bioanalytical laboratories.

 

For Phase II–IV, PharmaNet offers a comprehensive range of clinical development services. Dedicated specialty teams conduct studies in virtually all therapeutic and specialty areas, including oncology, cardiology, dermatology, infectious diseases, neurosciences, ophthalmology, women’s health and pediatrics. These PharmaNet teams have the capabilities and dedicated resources to implement programs of any scale, regional and global. 

 

World Courier

 

The shipment of infectious or diagnostic biological samples and clinical trial supplies requires expert handling. World Courier is a pioneer in the transport of sensitive medical and pharmaceutical shipments, delivering the first human heart tissue for transplant in 1984.  Specialising in the transport of temperature controlled and time critical samples; World Courier is committed to handling every consignment on an individual, priority basis. This translates into a premium service where our experienced staff ensure that your shipment arrives on time and in perfect condition.

 

With in-house scientists to understand your needs, World Courier can recommend and provide appropriate packaging and refrigerants to ensure the integrity of your temperature controlled shipment. Documentation and regulatory requirements are managed by World Courier to ensure your shipment complies with country requirements.  Your shipment is dispatched on the first available flight and actively monitored throughout its journey. Confirmation of the delivery is provided immediately upon arrival.

 

Investor Sponsor

Abingworth

Abingworth is an international investment group dedicated exclusively to the life sciences and healthcare sectors. We invest across all stages of company development including early and late-stage venture financing, growth equity and public companies.

Founded in 1973, Abingworth has a lengthy track record of building market leading companies. Our specialist team of over 20 professionals has a broad range of skills, including scientific and business expertise as well as investment banking, recruitment and legal knowledge. These resources are made available to portfolio companies. Abingworth has funds under management of over $1.25 billion and offices in London, Menlo Park (California) and Boston.

Project Partners

Thames Valley Life Sciences Network

The Thames Valley Life Sciences Network aims to promote and stimulate innovation and enterprise in the Life Sciences and Healthcare industries throughout the Thames Valley.  Businesses and organisations of all sizes come together through TVLSN to share the latest research and technologies and maximise opportunities for growth in the sector. TVLSN hosts regular networking events focusing on Life Science topics together with a series of half and one day meetings. TVLSN is part of the Thames Valley Innovation and Growth Team that provides support for high growth, innovative businesses.